# Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

> **NCT05821101** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Debbie S. Kuo, MD** · enrollment: 30 (estimated)

## Conditions studied

- Aphakia, Postcataract

## Interventions

- **DEVICE:** Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50.

## Key facts

- **NCT ID:** NCT05821101
- **Lead sponsor:** Debbie S. Kuo, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-06
- **Primary completion:** 2025-01-31
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05821101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05821101, "Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05821101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*